JPS6030689A - 生理活性物質ｓｐｆ−１及びその製法 - Google Patents
生理活性物質ｓｐｆ−１及びその製法Info
- Publication number
- JPS6030689A JPS6030689A JP58139385A JP13938583A JPS6030689A JP S6030689 A JPS6030689 A JP S6030689A JP 58139385 A JP58139385 A JP 58139385A JP 13938583 A JP13938583 A JP 13938583A JP S6030689 A JPS6030689 A JP S6030689A
- Authority
- JP
- Japan
- Prior art keywords
- physiologically active
- substance
- active substance
- culture
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013543 active substance Substances 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims abstract description 28
- 239000000126 substance Substances 0.000 claims abstract description 24
- 238000012258 culturing Methods 0.000 claims abstract description 12
- 229930182555 Penicillin Natural products 0.000 claims abstract description 8
- 229940049954 penicillin Drugs 0.000 claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 241000194017 Streptococcus Species 0.000 claims description 12
- 238000000862 absorption spectrum Methods 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 238000002523 gelfiltration Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 238000000921 elemental analysis Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims description 2
- 102000009027 Albumins Human genes 0.000 claims description 2
- 108010088751 Albumins Proteins 0.000 claims description 2
- 102000006395 Globulins Human genes 0.000 claims description 2
- 108010044091 Globulins Proteins 0.000 claims description 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 claims description 2
- 229960003067 cystine Drugs 0.000 claims description 2
- 238000000354 decomposition reaction Methods 0.000 claims description 2
- -1 imbutanol Chemical compound 0.000 claims description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 2
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 claims 1
- 229940056360 penicillin g Drugs 0.000 abstract description 10
- 230000000259 anti-tumor effect Effects 0.000 abstract description 6
- 241000187747 Streptomyces Species 0.000 abstract 3
- 230000000813 microbial effect Effects 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 38
- 239000002609 medium Substances 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 17
- 230000001580 bacterial effect Effects 0.000 description 15
- 238000003756 stirring Methods 0.000 description 9
- 235000013372 meat Nutrition 0.000 description 7
- 241000193996 Streptococcus pyogenes Species 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 229920005654 Sephadex Polymers 0.000 description 4
- 239000012507 Sephadex™ Substances 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- WHBHBVVOGNECLV-OBQKJFGGSA-N 11-deoxycortisol Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 WHBHBVVOGNECLV-OBQKJFGGSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000007621 bhi medium Substances 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58139385A JPS6030689A (ja) | 1983-08-01 | 1983-08-01 | 生理活性物質ｓｐｆ−１及びその製法 |
| CA000459394A CA1237085A (en) | 1983-08-01 | 1984-07-20 | Spf-100 and process for the preparation thereof |
| GB08418745A GB2146028B (en) | 1983-08-01 | 1984-07-23 | Spf-100 and process for the preparation thereof |
| AU31000/84A AU572529B2 (en) | 1983-08-01 | 1984-07-24 | Spf-100 and process for the preparation thereof |
| CH3684/84A CH663033A5 (fr) | 1983-08-01 | 1984-07-30 | Substance-melange dite ''spf-100'' et procede pour sa preparation. |
| DE19843428017 DE3428017A1 (de) | 1983-08-01 | 1984-07-30 | Spf-100 und verfahren zu seiner herstellung |
| KR1019840004559A KR850002276A (ko) | 1983-08-01 | 1984-07-31 | Spf-100의 제조방법 |
| NL8402388A NL8402388A (nl) | 1983-08-01 | 1984-07-31 | Geneesmiddel spf-100 en werkwijze voor de bereiding hiervan. |
| FR8412119A FR2550223B1 (fr) | 1983-08-01 | 1984-07-31 | Spf-100 et procede de preparation |
| SE8403914A SE461532B (sv) | 1983-08-01 | 1984-07-31 | Cancermotverkande och immunaktiverande aemne (spf-100) |
| US06/746,514 US4656037A (en) | 1983-08-01 | 1985-06-19 | SPF-100 and process for the preparation thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58139385A JPS6030689A (ja) | 1983-08-01 | 1983-08-01 | 生理活性物質ｓｐｆ−１及びその製法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6030689A true JPS6030689A (ja) | 1985-02-16 |
| JPS6250475B2 JPS6250475B2 (enrdf_load_stackoverflow) | 1987-10-24 |
Family
ID=15244077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58139385A Granted JPS6030689A (ja) | 1983-08-01 | 1983-08-01 | 生理活性物質ｓｐｆ−１及びその製法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6030689A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03502674A (ja) * | 1987-12-21 | 1991-06-20 | デイビッド ジー．エバンス アンド アソシエーツ プロプライエタリー リミテッド | 密封容器 |
-
1983
- 1983-08-01 JP JP58139385A patent/JPS6030689A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03502674A (ja) * | 1987-12-21 | 1991-06-20 | デイビッド ジー．エバンス アンド アソシエーツ プロプライエタリー リミテッド | 密封容器 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6250475B2 (enrdf_load_stackoverflow) | 1987-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Horio et al. | Preparation of crystalline Pseudomonas cytochrome c-551 and its general properties | |
| EP0030812B1 (en) | A process for preparing substances having interferon inducing activity and interferon inducers | |
| JPS61158997A (ja) | ポリペプチド抗生物質 | |
| US4656037A (en) | SPF-100 and process for the preparation thereof | |
| JPS6030689A (ja) | 生理活性物質ｓｐｆ−１及びその製法 | |
| JPS59135886A (ja) | ビリルビン・オキシダ−ゼの製造法 | |
| JPS60218324A (ja) | 生理活性物質ｓｐｆ−２及びその製法 | |
| Hosokawa et al. | Higher plants contain L-asparate oxidase, the first enzyme of the Escherichia coli quinolinate synthetase system | |
| JPS6092218A (ja) | 抗腫瘍性物質の製造法 | |
| JPH0156077B2 (enrdf_load_stackoverflow) | ||
| JPS60197626A (ja) | 血圧降下剤 | |
| JPH0156078B2 (enrdf_load_stackoverflow) | ||
| RU2039823C1 (ru) | Способ получения рекомбинантного лимфотоксина человека | |
| JPH026511B2 (enrdf_load_stackoverflow) | ||
| JPS60218323A (ja) | 抗腫瘍性物質ｓｐｆ―１０００及びその製法 | |
| JPS60239424A (ja) | 抗腫瘍性物質ｓｐｆ―１０００及びその製法 | |
| JPS6047686A (ja) | 抗インフルエンザウイルス物質アガラクチンおよびその製造法 | |
| JPS6043387A (ja) | 抗腫瘍性物質およびその製造法 | |
| JPS62285A (ja) | キラ−因子Ｋｈ−２及びその製造法 | |
| JPH01299264A (ja) | 新規物質ｆｌ−６５７ｃ及びその製造法 | |
| JPS6326994B2 (enrdf_load_stackoverflow) | ||
| Griffith et al. | Nicotine Oxidation by Arthrobacter | |
| JPS6399087A (ja) | 物質ｋｂｓ２−ｐ１０４及びその製造法 | |
| JPS6399084A (ja) | 物質ｋｂｓ１−ｐ１０７及びその製造法 | |
| JPH0156074B2 (enrdf_load_stackoverflow) |